Pulmonary embolism (PE) is a serious medical condition in which a blood clot blocks one of the arteries in the lungs. It can be life-threatening and is a leading cause of death in the United States. The impact of PE on life expectancy can be significant, and it is important for doctors to understand the diagnosis and treatment of this condition. This article will explore the impact of PE on life expectancy, including the risk factors, diagnosis, and treatment options.
PE is more common in certain populations than others. People who are at an increased risk of developing PE include those who are over the age of 60, those who have had recent surgery, those who have been immobile for a long period of time, those who have had a recent injury, those who have had a recent heart attack or stroke, and those who have a family history of PE. Additionally, certain medical conditions such as cancer, heart failure, and deep vein thrombosis (DVT) can increase the risk of PE.
The diagnosis of PE is based on a combination of clinical evaluation, laboratory tests, and imaging studies. The most common laboratory test used to diagnose PE is a D-dimer test, which measures the amount of a protein that is released when a blood clot is present. Other tests that may be used to diagnose PE include a chest X-ray, a computed tomography (CT) scan, and an echocardiogram.
Once a diagnosis of PE has been made, the treatment options will depend on the severity of the condition. The primary treatment for PE is anticoagulant therapy, which helps to prevent the formation of new blood clots. Anticoagulant therapy is typically given in the form of injections or pills. In some cases, surgery may be recommended to remove the clot and restore blood flow.
The impact of PE on life expectancy can be significant. People who have had a PE are at an increased risk of developing another PE, or of having a stroke or heart attack. Additionally, those who have had a PE are more likely to have long-term complications such as chronic pulmonary hypertension, which can reduce life expectancy.
Pulmonary embolism is a serious medical condition that can have a significant impact on life expectancy. It is important for doctors to understand the risk factors, diagnosis, and treatment options for PE in order to provide the best possible care for their patients. With proper diagnosis and treatment, the impact of PE on life expectancy can be minimized.
1.
Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer
2.
Pediatric high-grade gliomas: Research reveals effective targeting with avapritinib
3.
In prostate cancer survivorship, sleep disturbances are underappreciated.
4.
Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer
5.
a cutting-edge cancer diagnostic tool.
1.
Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms
2.
Community Survivorship Networks for Long-Term Cancer Wellness
3.
Neuroendocrine Tumors: Case Study on Diagnosis, Treatment Strategies & Patient Management
4.
Targeted Therapies for Breast Cancer: What’s New?
5.
Integrated Insights in Hematology and Quality Improvement
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Hands-on Workshop: Hematology
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation